100 Clinical Results associated with Zhejiang Haisen Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Zhejiang Haisen Pharmaceutical Co., Ltd.
Determination of escitalopram oxalate tablets by HPLC
Author: Dai, Ya ; Wang, Xianguang ; Fu, Tao ; Chen, Liping ; Yu, Lijun
A HPLC method for the assay of Escitalopram Oxalate Tablets was established.The HPLC method was used with C18 column (250 mm×4.6 mm, 5 μm).The mobile phase was phosphoric acid buffer solution-methanol (51: 49), with the detection wavelength at 238 nm.The linear range of escitalopram was 25-150 μg/mL (r=0.9999).The average recovery rate was 99.60%, RSD=0.44%.This method is convenient with good specificity and good reproducibility for the assay of Escitalopram Oxalate Tablets.
New synthesis of 5-cyanophthalide
Author: Wang, Xianguang ; Fu, Tao ; Dai, Ya ; Li, Kuanwei ; Hu, Kangkang
A new synthetic method of 5-cyanophthalide as an important intermediate of citalopram was established.The compound 5-cyanophthalide I was prepared by reaction of 5-formylphthalide with hydroxylamine hydrochloride at reflux conditions for 40 min in formic acid (5-formylphthalide:hydroxylamine hydrochloride = 1:1.2 mol/mol).The yield rate could reach to 83%.This method was simple in technol. with high yields, low cost and better application prospect.
Origin of 4-N-demethylanalgin impurity and its synthesis in laboratory
Author: Hu, Kangkang ; Wu, Hongli ; Fu, Tao
The impurity 4-N-demethylanalgin formed in preparing analgin and its causes were analyzed to synthesize it in laboratory4-N-demethylanalgin is prepared by the reflux reaction of aminoantipyrine (AA) with sodium pyrosulphite and formaldehyde for 40 min in ethanol (pure aminoantipyrine: sodium pyrosulphite: formaldehyde=1:0.65:1.1) and the yield rate was 67%-73%.4-N-demethylanalgin is formed by the condensation reaction of AA with sodium pyrosulphite and formaldehyde in the production process of analgin.
100 Deals associated with Zhejiang Haisen Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Zhejiang Haisen Pharmaceutical Co., Ltd.